| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | HOXA11 SOX15 TWIST2 ZNF630 ZNF528 HOXC11 ZNF442 THAP1 TET3 ZNF425 ZNF582 ZNF549 HOXB13 NTN3 | 9.54e-08 | 1459 | 36 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HOXA11 SOX15 TWIST2 ZNF630 ZNF528 HOXC11 ZNF442 THAP1 ZNF425 ZNF582 ZNF549 HOXB13 NTN3 | 5.19e-07 | 1412 | 36 | 13 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | HOXA11 SOX15 ZNF630 ZNF528 HOXC11 THAP1 TET3 ZNF549 HOXB13 NTN3 | 4.85e-05 | 1244 | 36 | 10 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | HOXA11 SOX15 ZNF630 ZNF528 HOXC11 THAP1 TET3 ZNF549 HOXB13 NTN3 | 5.82e-05 | 1271 | 36 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | methyl-CpG binding | 1.42e-03 | 31 | 36 | 2 | GO:0008327 | |
| GeneOntologyBiologicalProcess | organ induction | 1.23e-05 | 26 | 36 | 3 | GO:0001759 | |
| GeneOntologyBiologicalProcess | metanephros development | 2.22e-05 | 95 | 36 | 4 | GO:0001656 | |
| GeneOntologyBiologicalProcess | regulation of animal organ formation | 2.34e-05 | 32 | 36 | 3 | GO:0003156 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 4.97e-05 | 41 | 36 | 3 | GO:0010092 | |
| GeneOntologyBiologicalProcess | positive regulation of animal organ morphogenesis | 4.97e-05 | 41 | 36 | 3 | GO:0110110 | |
| GeneOntologyBiologicalProcess | developmental induction | 4.97e-05 | 41 | 36 | 3 | GO:0031128 | |
| GeneOntologyBiologicalProcess | male gonad development | 2.18e-04 | 171 | 36 | 4 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 2.23e-04 | 172 | 36 | 4 | GO:0046546 | |
| GeneOntologyBiologicalProcess | embryonic skeletal joint morphogenesis | 2.28e-04 | 13 | 36 | 2 | GO:0060272 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 2.55e-04 | 178 | 36 | 4 | GO:0022612 | |
| GeneOntologyBiologicalProcess | animal organ formation | 3.40e-04 | 78 | 36 | 3 | GO:0048645 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 3.89e-04 | 199 | 36 | 4 | GO:0046661 | |
| GeneOntologyBiologicalProcess | embryonic skeletal joint development | 3.96e-04 | 17 | 36 | 2 | GO:0072498 | |
| GeneOntologyBiologicalProcess | kidney development | 4.42e-04 | 372 | 36 | 5 | GO:0001822 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle tissue development | 4.45e-04 | 18 | 36 | 2 | GO:1901862 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 5.05e-04 | 383 | 36 | 5 | GO:0048608 | |
| GeneOntologyBiologicalProcess | renal system development | 5.23e-04 | 386 | 36 | 5 | GO:0072001 | |
| GeneOntologyBiologicalProcess | reproductive system development | 5.35e-04 | 388 | 36 | 5 | GO:0061458 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 7.02e-04 | 412 | 36 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 7.38e-04 | 236 | 36 | 4 | GO:0061138 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 8.56e-04 | 107 | 36 | 3 | GO:0001657 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 9.03e-04 | 109 | 36 | 3 | GO:0048704 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 9.27e-04 | 110 | 36 | 3 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 9.27e-04 | 110 | 36 | 3 | GO:0072163 | |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 9.27e-04 | 110 | 36 | 3 | GO:2000027 | |
| GeneOntologyBiologicalProcess | mesonephros development | 1.00e-03 | 113 | 36 | 3 | GO:0001823 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.03e-03 | 258 | 36 | 4 | GO:0001763 | |
| Domain | KRAB | 3.80e-06 | 358 | 35 | 7 | PS50805 | |
| Domain | KRAB | 3.80e-06 | 358 | 35 | 7 | PF01352 | |
| Domain | KRAB | 4.63e-06 | 369 | 35 | 7 | SM00349 | |
| Domain | KRAB | 4.72e-06 | 370 | 35 | 7 | IPR001909 | |
| Domain | DUF3528 | 1.02e-05 | 3 | 35 | 2 | PF12045 | |
| Domain | DUF3528 | 1.02e-05 | 3 | 35 | 2 | IPR021918 | |
| Domain | zf-C2H2 | 3.34e-05 | 693 | 35 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 3.37e-05 | 694 | 35 | 8 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 7.36e-05 | 775 | 35 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 7.50e-05 | 777 | 35 | 8 | PS00028 | |
| Domain | Znf_C2H2-like | 8.88e-05 | 796 | 35 | 8 | IPR015880 | |
| Domain | Znf_C2H2 | 9.60e-05 | 805 | 35 | 8 | IPR007087 | |
| Domain | ZnF_C2H2 | 9.85e-05 | 808 | 35 | 8 | SM00355 | |
| Domain | - | 2.25e-04 | 679 | 35 | 7 | 3.30.160.60 | |
| Domain | zf-C2H2_6 | 2.79e-04 | 314 | 35 | 5 | PF13912 | |
| Domain | Growth_fac_rcpt_ | 3.08e-03 | 156 | 35 | 3 | IPR009030 | |
| Domain | Homeobox_CS | 5.03e-03 | 186 | 35 | 3 | IPR017970 | |
| Domain | Homeobox | 9.46e-03 | 234 | 35 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 9.68e-03 | 236 | 35 | 3 | PS00027 | |
| Domain | HOX | 9.79e-03 | 237 | 35 | 3 | SM00389 | |
| Domain | Homeobox_dom | 1.00e-02 | 239 | 35 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.00e-02 | 239 | 35 | 3 | PS50071 | |
| Domain | EGF_1 | 1.19e-02 | 255 | 35 | 3 | PS00022 | |
| Domain | Homeobox_metazoa | 1.23e-02 | 90 | 35 | 2 | IPR020479 | |
| Domain | EGF-like_CS | 1.27e-02 | 261 | 35 | 3 | IPR013032 | |
| Domain | EGF_2 | 1.32e-02 | 265 | 35 | 3 | PS01186 | |
| Pathway | REACTOME_FORMATION_OF_THE_URETERIC_BUD | 8.14e-06 | 21 | 27 | 3 | M48244 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 9.00e-05 | 46 | 27 | 3 | M48243 | |
| Pubmed | 6.82e-06 | 118 | 36 | 4 | 16971476 | ||
| Pubmed | 8.38e-06 | 38 | 36 | 3 | 11857506 | ||
| Pubmed | Quantification of Hox and surfactant protein-B transcription during murine lung development. | 9.80e-06 | 40 | 36 | 3 | 19204410 | |
| Pubmed | Generation and expression of a Hoxa11eGFP targeted allele in mice. | 1.04e-05 | 5 | 36 | 2 | 18942146 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 34010606 | ||
| Pubmed | 1.06e-05 | 41 | 36 | 3 | 32479258 | ||
| Pubmed | 1.14e-05 | 42 | 36 | 3 | 34673265 | ||
| Pubmed | 1.22e-05 | 43 | 36 | 3 | 22701719 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 7873879 | ||
| Pubmed | New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice. | 1.93e-05 | 50 | 36 | 3 | 28188179 | |
| Pubmed | Hox11-expressing interstitial cells contribute to adult skeletal muscle at homeostasis. | 2.18e-05 | 7 | 36 | 2 | 36815629 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 19716816 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 20978074 | ||
| Pubmed | Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton. | 2.91e-05 | 8 | 36 | 2 | 12869760 | |
| Pubmed | Hox11 paralogous genes are essential for metanephric kidney induction. | 2.91e-05 | 8 | 36 | 2 | 12050119 | |
| Pubmed | Tetrapod axial evolution and developmental constraints; Empirical underpinning by a mouse model. | 2.91e-05 | 8 | 36 | 2 | 26238020 | |
| Pubmed | AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. | 2.91e-05 | 8 | 36 | 2 | 9343407 | |
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 28939119 | ||
| Pubmed | Targeted disruption of Hotair leads to homeotic transformation and gene derepression. | 4.66e-05 | 10 | 36 | 2 | 24075995 | |
| Pubmed | 5.55e-05 | 71 | 36 | 3 | 33541421 | ||
| Pubmed | Roundabout receptors are critical for foregut separation from the body wall. | 6.83e-05 | 12 | 36 | 2 | 23328398 | |
| Pubmed | 8.07e-05 | 13 | 36 | 2 | 35017475 | ||
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 15617687 | ||
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 18485340 | ||
| Pubmed | Hoxa11 and Hoxd11 regulate branching morphogenesis of the ureteric bud in the developing kidney. | 9.41e-05 | 14 | 36 | 2 | 11493536 | |
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 9342041 | ||
| Pubmed | Distal Limb Patterning Requires Modulation of cis-Regulatory Activities by HOX13. | 1.24e-04 | 16 | 36 | 2 | 27974206 | |
| Pubmed | A Hox Code Defines Spinocerebellar Neuron Subtype Regionalization. | 1.24e-04 | 16 | 36 | 2 | 31747609 | |
| Pubmed | 1.24e-04 | 93 | 36 | 3 | 7829101 | ||
| Pubmed | 1.40e-04 | 17 | 36 | 2 | 17626057 | ||
| Pubmed | 1.76e-04 | 19 | 36 | 2 | 21858105 | ||
| Pubmed | 1.96e-04 | 20 | 36 | 2 | 33397958 | ||
| Pubmed | Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs. | 2.38e-04 | 22 | 36 | 2 | 26283362 | |
| Pubmed | Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy. | 3.08e-04 | 25 | 36 | 2 | 11698278 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 3.14e-04 | 1294 | 36 | 7 | 30804502 | |
| Pubmed | 3.33e-04 | 26 | 36 | 2 | 8646877 | ||
| Pubmed | 3.60e-04 | 27 | 36 | 2 | 20417598 | ||
| Pubmed | 4.16e-04 | 29 | 36 | 2 | 2574852 | ||
| Pubmed | Ndrg2 regulates vertebral specification in differentiating somites. | 5.07e-04 | 32 | 36 | 2 | 22819676 | |
| Pubmed | Distinct roles and regulations for HoxD genes in metanephric kidney development. | 5.39e-04 | 33 | 36 | 2 | 18159948 | |
| Pubmed | 6.45e-04 | 383 | 36 | 4 | 19453261 | ||
| Pubmed | 7.15e-04 | 38 | 36 | 2 | 1683707 | ||
| Pubmed | 7.15e-04 | 38 | 36 | 2 | 15042701 | ||
| Pubmed | Epicardial cell shape and maturation are regulated by Wt1 via transcriptional control of Bmp4. | 7.15e-04 | 38 | 36 | 2 | 31624071 | |
| Pubmed | 7.54e-04 | 39 | 36 | 2 | 33257809 | ||
| Pubmed | 9.59e-04 | 44 | 36 | 2 | 1973146 | ||
| Cytoband | 17q21.2 | 1.40e-03 | 70 | 36 | 2 | 17q21.2 | |
| Cytoband | 19q13.43 | 2.14e-03 | 87 | 36 | 2 | 19q13.43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p15 | 2.88e-03 | 101 | 36 | 2 | chr7p15 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.75e-06 | 718 | 27 | 8 | 28 | |
| GeneFamily | HOXL subclass homeoboxes | 6.25e-05 | 52 | 27 | 3 | 518 | |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_DN | 1.59e-06 | 145 | 36 | 5 | M14098 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.25e-08 | 200 | 36 | 6 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-07 | 179 | 36 | 5 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-07 | 191 | 36 | 5 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 4.55e-07 | 192 | 36 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.67e-07 | 193 | 36 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.67e-07 | 193 | 36 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.79e-07 | 194 | 36 | 5 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.91e-07 | 195 | 36 | 5 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 4.91e-07 | 195 | 36 | 5 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 5.04e-07 | 196 | 36 | 5 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.04e-07 | 196 | 36 | 5 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 5.04e-07 | 196 | 36 | 5 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 5.16e-07 | 197 | 36 | 5 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-07 | 198 | 36 | 5 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-07 | 198 | 36 | 5 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.29e-07 | 198 | 36 | 5 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 5.29e-07 | 198 | 36 | 5 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.29e-07 | 198 | 36 | 5 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-07 | 198 | 36 | 5 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.29e-07 | 198 | 36 | 5 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | COPD-Stromal-Fibroblast|COPD / Disease state, Lineage and Cell class | 5.29e-07 | 198 | 36 | 5 | 7904af61473cb20064f7a3a1e1bfe8d5913cf317 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 5.29e-07 | 198 | 36 | 5 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.29e-07 | 198 | 36 | 5 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-07 | 199 | 36 | 5 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-07 | 199 | 36 | 5 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 368C-Fibroblasts|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-07 | 199 | 36 | 5 | dbf64b83e2dc311b68f299c3f306ee098efd664c | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-07 | 199 | 36 | 5 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.43e-07 | 199 | 36 | 5 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-07 | 199 | 36 | 5 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-07 | 199 | 36 | 5 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.43e-07 | 199 | 36 | 5 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-07 | 199 | 36 | 5 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-07 | 199 | 36 | 5 | 136f24597ddca5cf2175120975c94782a3232ec6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.56e-07 | 200 | 36 | 5 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-07 | 200 | 36 | 5 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.56e-07 | 200 | 36 | 5 | 28e5354008adf97b17333f17f8cbef930db6729a | |
| ToppCell | 356C-Fibroblasts|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-07 | 200 | 36 | 5 | 9c95329f0b26ff378de803030d4c28517b3adc85 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-07 | 200 | 36 | 5 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 5.56e-07 | 200 | 36 | 5 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.56e-07 | 200 | 36 | 5 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.56e-07 | 200 | 36 | 5 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-07 | 200 | 36 | 5 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.56e-07 | 200 | 36 | 5 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.56e-07 | 200 | 36 | 5 | ef30f9b68bfdb8d947ed399603e4dd0d5ff0144d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.56e-07 | 200 | 36 | 5 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-07 | 200 | 36 | 5 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.56e-07 | 200 | 36 | 5 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-07 | 200 | 36 | 5 | b28bfe6eb96b4db9cb27f0fc8fc39259c125f05e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.56e-07 | 200 | 36 | 5 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.56e-07 | 200 | 36 | 5 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.56e-07 | 200 | 36 | 5 | 56e838787385dd282caadeac24fbb0a706bf7f2b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-07 | 200 | 36 | 5 | 5c6520dc4c4693827f6680651785680b5883afb8 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.56e-07 | 200 | 36 | 5 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | distal-1-mesenchymal-Adventitial_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.56e-07 | 200 | 36 | 5 | 738060ed65fa5473fdb39e686f7cdecc059ed92c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-07 | 200 | 36 | 5 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.56e-07 | 200 | 36 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.56e-07 | 200 | 36 | 5 | 56536236a7012efdb28f85b40e464f3da3e87ce8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-07 | 200 | 36 | 5 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.56e-07 | 200 | 36 | 5 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.56e-07 | 200 | 36 | 5 | 687cfada2d0977e8985e0a73a5804f84f2ca9c52 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.56e-07 | 200 | 36 | 5 | 87953ea65ff2a01485e13dd49d993ae6ae679cbf | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.14e-06 | 154 | 36 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.14e-06 | 154 | 36 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.90e-06 | 158 | 36 | 4 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 168 | 36 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 169 | 36 | 4 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 169 | 36 | 4 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 171 | 36 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 175 | 36 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.21e-05 | 176 | 36 | 4 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 176 | 36 | 4 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 176 | 36 | 4 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 178 | 36 | 4 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 178 | 36 | 4 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.29e-05 | 179 | 36 | 4 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-05 | 180 | 36 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-05 | 180 | 36 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 180 | 36 | 4 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 180 | 36 | 4 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.35e-05 | 181 | 36 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 181 | 36 | 4 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 182 | 36 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 182 | 36 | 4 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 183 | 36 | 4 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 183 | 36 | 4 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 183 | 36 | 4 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-05 | 184 | 36 | 4 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.44e-05 | 184 | 36 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.47e-05 | 185 | 36 | 4 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-05 | 185 | 36 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 185 | 36 | 4 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.47e-05 | 185 | 36 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 185 | 36 | 4 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.47e-05 | 185 | 36 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 186 | 36 | 4 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-05 | 188 | 36 | 4 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-05 | 189 | 36 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.63e-05 | 190 | 36 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-05 | 191 | 36 | 4 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-05 | 191 | 36 | 4 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| Drug | Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; HL60; HT_HG-U133A | 6.47e-07 | 199 | 36 | 6 | 3066_UP | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.36e-05 | 196 | 36 | 5 | 6323_DN | |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; HL60; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 2500_DN | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 6378_DN | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 3.10e-04 | 24 | 32 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | endometrial cancer (is_marker_for) | 6.63e-04 | 35 | 32 | 2 | DOID:1380 (is_marker_for) | |
| Disease | visceral adipose tissue measurement | 1.75e-03 | 481 | 32 | 4 | EFO_0004765 | |
| Disease | central corneal thickness | 4.51e-03 | 309 | 32 | 3 | EFO_0005213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKPQIKRGKRRYCNT | 816 | Q4LE39 | |
| SPQGKYSKRKGRFKR | 26 | Q02641 | |
| ESRKKRGCSSSKYAP | 1106 | Q6PL18 | |
| RKSKSTCYKSKGYRP | 396 | Q7Z3Y9 | |
| RYKRKGDSCLGINPK | 186 | Q9H7Z3 | |
| RKGFYKRKQCKPSRG | 221 | P24593 | |
| RFYGKRSRAEAPLKC | 336 | Q9Y546 | |
| EFYSFRRRKTIGGKC | 296 | Q96GN5 | |
| SSGQRTRKKRCPYTK | 236 | P31270 | |
| CGPGLRKTKYRSFRR | 361 | Q7Z6J2 | |
| KPARGSYRISLKKFC | 446 | O00634 | |
| RNIPGCVKTYSKAKR | 316 | P49619 | |
| YECKINGYPKRGRKR | 2716 | P35555 | |
| RTRKKRCPYSKFQIR | 231 | O43248 | |
| SAGKSSSYLKKCRRR | 76 | Q69YH5 | |
| CAFRRGRKKRIPYSK | 211 | Q92826 | |
| FSRGYPIRQSSKCRK | 146 | Q9UPX6 | |
| LKKNGSCKRGPRTHY | 126 | P05230 | |
| SLSYRCKRKRGGAKD | 266 | Q1XH10 | |
| GGLYKPRRRYKASCS | 606 | Q14940 | |
| CFPYARQDKKDKSRS | 91 | P21108 | |
| RKEYAGKRKGCFSKR | 1286 | O94911 | |
| YKYRPRRKAKSSGAG | 116 | O60248 | |
| GKCGKAFNKRYSLVR | 616 | Q6P9A3 | |
| RRKNFKPTKYSSICS | 41 | Q9NVV9 | |
| KRRKSYRSFLPEKSG | 1236 | Q9C0C9 | |
| CCGPLRSKRRKYSFE | 1491 | O94813 | |
| NGCKYARSKTPRKFR | 991 | O43151 | |
| KPFKCDTCGKNFRRR | 286 | Q14588 | |
| RSYARKNPTKRFRCG | 196 | Q2M218 | |
| TREKPFGYNKCRKDF | 166 | Q96NG8 | |
| RGRPAKGRRASYKCK | 3076 | Q96JG9 | |
| KPYKCKRCGRAFSVS | 291 | Q9H7R0 | |
| KPYKCNRCGKVFSRS | 491 | Q3MIS6 | |
| QLCRYPKYKNSSRGK | 216 | Q6IV72 | |
| PKRFGRKRRYSKKSS | 26 | Q8WVJ9 |